U.S. market Closed. Opens in 5 hours 24 minutes

RPRX | Royalty Pharma plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue2.35B2.24B2.29B2.12B1.81B1.79B1.58B
Cost of Revenue560.66M5.67M23.00M88.11M1.02B135.96MN/A
Gross Profit1.79B2.23B2.27B2.03B794.93M1.66BN/A
Operating Expenses862.40M1.31B858.75M527.00M-808.92M430.45M637.82M
Selling, General & Admin249.75M227.30M182.83M182.00M103.44M61.91M106.44M
Research & Development52.00M177.11M200.08M26.00M83.04M392.61M117.87M
Other Operating Expenses-560.66M909.91M475.84M319.00M-995.40M-1.52M413.51M
Operating Income1.49B977.50M1.43B1.59B2.62B1.36B939.69M
Other Expenses / Income207.94M-747.43M-189.51M107.00M-161.76M408.92M403.49M
Before Tax Income1.70B230.06M1.24B1.70B2.46B1.52B1.34B
Income Tax Expenses565.25M187.23M762.45M1.15B349.33M433.37MN/A
Net Income1.13B42.83M478.75M495.20M2.35B1.38B1.21B
Interest Expenses187.19M187.96M166.14M157.00M268.57M279.96M247.34M
Basic Shares Outstanding447.60M437.96M414.79M375.44M365.90M354.18M354.18M
Diluted Shares Outstanding602.90M437.97M414.80M375.45M365.90M354.18M354.18M
EBITDA1.49B983.17M1.48B1.88B2.64B1.41B1.49B
EBITDA Margin63.37%43.95%64.73%88.69%145.37%78.76%94.49%
EBIT1.89B418.02M1.41B1.80B2.97B2.09B1.46B
EBIT Margin80.15%18.69%61.47%84.79%163.51%116.50%92.38%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙